Business Daily from THE HINDU group of publications
Monday, Oct 29, 2007
ePaper | Mobile/PDA Version


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Outlook
Sparsha to invest $20 m in pain-relief drug unit

Our Bureau

Hyderabad, Oct. 28 Sparsha Pharma International, which plans to manufacture low-cost transdermal patch products for pain relief, has decided to invest up to $20 million in production facilities in the country over the long term.

Promoted by a group of US-based NRIs with support from Japanese, the company is setting up its base in Muppireddy Palli village in Medak district of Andhra Pradesh.

In phase-I, the company will invest $6 million, mostly from the promoters’ funds, to establish facilities, transfer proprietary technology and make three products – Fentanel, nitroglycerine and hormonal patches.

Sparsha has acquired 10 acres of land from the Andhra Pradesh Industrial Infrastructure Corporation. Mr Bobba Venkatadri, one of the key NRI promoters, said by end 2009 or early 2010 the company expects to launch the products in the Indian and global markets. For the domestic market, the price would be ten times lower. At present some of these products cost about Rs 1,000-1,200 per patch at import prices, he said. The Japanese, a select few companies, whose top executives are associated in their individual capacities, would help both in technical expertise and funding, he said, without giving details. Venture capital funding would be an option in the Phase-II, when about $14 million would be raised, Mr Bobba added.

More Stories on : Outlook | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
ECIL pays Rs 31-cr dividend


With real estate booming, foreign architects in demand
Ratnagiri Gas equity structure in for change
‘Good business will only survive because of good values’
Murata Machinery setting up Indian subsidiary
Dutch gas major plans hi-drive LPG stations
Ocean India starts work on Brandix apparel park unit
‘Texmaco finalising partner for railway projects’
Marg Constructions, Malaysian co tie up for Karaikal port
Sparsha to invest $20 m in pain-relief drug unit
ONGC lines up Rs 7,750 cr to revamp onshore assets
Rising rupee helps some companies shore up profits
Kerala PSUs under Agri Dept do well
Alufluoride sales up by 14%
SAIL ramps up iron ore production


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line